Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group

American Journal of Hematology

Volumn 87, Issue 7, 2012, Pages 663-668

  Tse, Eric ^a   Gill, Harinder ^a   Loong, Florence ^a   Kim, Seok Jin ^b   Ng, Siok Bian ^c,d   Tang, Tiffany ^e   Ko, Young Hyeh ^f   Chng, Wee Joo ^d,g   Lim, Soon Thye ^e   Kim, Won Seog ^b   Kwong, Yok Lam ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b Samsung Medical Center   (South Korea)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^f Sungkyunkwan University   (South Korea)

^g NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN;

ADULT; AGE; AGED; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CANCER SURGERY; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; EPSTEIN BARR VIRUS; FEMALE; GASTROINTESTINAL PAIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; LARGE INTESTINE; LYMPHOCYTIC INFILTRATION; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SMALL INTESTINE; STOMACH; TREATMENT RESPONSE;

ABDOMINAL PAIN; ADULT; AGED; AGED, 80 AND OVER; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; FEMALE; GASTROINTESTINAL NEOPLASMS; HONG KONG; HUMANS; INTESTINAL OBSTRUCTION; INTESTINAL PERFORATION; MALE; MIDDLE AGED; NEOPLASM STAGING; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SINGAPORE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84862568154     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23213     Document Type: Article

References (23)

1. Isaacson PG, Chott A, Ott G, et al. Enteropathy-associated T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: IARC; 2008. pp 289-291.
2. Muller-Hermelink HK, Delaie J, Ko YH, et al. T-cell lymphoma of the small intestine. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO Classification of Tumours of the Digestive System, 4th ed. Lyon: IARC; 2010. pp 112-114.
3. Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: Clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 2011; 118: 148-155.
4. Ferreri AJ, Zinzani PL, Govi S, Pileri SA. Enteropathy-associated T-cell lymphoma. Crit Rev Oncol Hematol 2011; 79: 84-90.
5. Chott A, Haedicke W, Mosberger I, et al. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 1998; 153: 1483-1490.
6. Akiyama T, Okino T, Konishi H, et al. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: Clinicopathology and molecular study of five Japanese patients. Pathol Int 2008; 58: 626-634.
7. Chuang SS, Chang ST, Chuang WY, et al. NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas. Am J Surg Pathol 2009; 33: 1230-1240.
8. Ko YH, Karnan S, Kim KM, et al. Enteropathy-associated T-cell lymphoma-A clinicopathologic and array comparative genomic hybridization study. Hum Pathol 2010; 41: 1231-1237.
9. Tung CL, Hsieh PP, Chang JH, et al. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: Natural killer-like cytotoxic T cell and true natural killer cell. Hum Pathol 2008; 39: 1018-1025.
10. Chan JK, Chan AC, Cheuk W, et al. Type II enteropathy-associated T-cell lymphoma: A distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am J Surg Pathol 2011; 35: 1557-1569.
11. Takeshita M, Nakamura S, Kikuma K, et al. Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan. Histopathology 2011; 58: 395-407.
12. Gill H, Ip AH, Leung R, et al. Indolent T-cell large granular lymphocyte leukaemia after haematopoietic SCT: A clinicopathologic and molecular analysis. Bone Marrow Transplant, 2011 Oct 31 [Epub ahead of print].
13. Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
14. Gallamini A, Stelitano C, Calvi R, et al. Intergruppo Italiano Linfomi. Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103: 2474-2479.
15. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-586.
16. Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: The NK-Cell Tumor Study Group Study. J Clin Oncol 2011; 29: 4410-4416.
17. Chuang SS, Liao YL, Liu H, et al. The phenotype of intraepithelial lymphocytes in Taiwanese enteropathy-associated T-cell lymphoma is distinct from that of the West. Histopathology 2008; 53: 234-236.
18. Sun J, Lu Z, Yang D, Chen J. Primary intestinal T-cell and NK-cell lymphomas: A clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma. Mod Pathol 2011; 24: 983-992.
19. Anthony MP, Kwong YL, Loong F, Khong PL. Positron emission tomography/computed tomography in monomorphic CD56+ intestinal T-cell lymphoma (type II enteropathy associated T-cell lymphoma). Clin Radiol 2012 (in press).
20. Hadithi M, Mallant M, Oudejans J, et al. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med 2006; 47: 1622-1627.
21. Garcia-Herrera A, Song JY, Chuang SS, et al. Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol 2011; 35: 1214-1225.
22. Verkarre V, Asnafi V, Lecomte T, et al. Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut 2003; 52: 205-211.
23. Sieniawski M, Angamuthu N, Boyd K, et al. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood 2010; 115: 3664-3670.